| scholarly article | Q13442814 |
| P2093 | author name string | Akira S | |
| Saito A | |||
| Takeda K | |||
| Kawakami K | |||
| Azuma M | |||
| Tohyama M | |||
| Kinjo Y | |||
| Koguchi Y | |||
| Uezu K | |||
| Yara S | |||
| P2860 | cites work | IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response | Q22009481 |
| Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit | Q24316432 | ||
| CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides | Q28254991 | ||
| Natural ligand of mouse CD1d1: cellular glycosylphosphatidylinositol. | Q32105308 | ||
| Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide | Q78145103 | ||
| Lipid antigen presentation in the immune system: lessons learned from CD1d knockout mice. | Q33713269 | ||
| Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates | Q33877219 | ||
| Early induction of interleukin-12 by human monocytes exposed to Cryptococcus neoformans mannoproteins. | Q34003199 | ||
| Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells | Q35534083 | ||
| Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12. | Q35545289 | ||
| Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells | Q36096376 | ||
| A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection | Q36366985 | ||
| High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. | Q36367196 | ||
| T helper cell type 1-associated and cytotoxic T lymphocyte-mediated tumor immunity is impaired in interleukin 4-deficient mice | Q36367817 | ||
| Interleukin (IL)-4 is a major regulatory cytokine governing bioactive IL-12 production by mouse and human dendritic cells | Q36368860 | ||
| Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans | Q36400205 | ||
| IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils | Q36704236 | ||
| alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria | Q37229005 | ||
| Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium | Q39509475 | ||
| Potentiality of interleukin-18 as a useful reagent for treatment and prevention of Leishmania major infection | Q39515412 | ||
| Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans | Q39517775 | ||
| Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans | Q39573339 | ||
| IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells | Q41011495 | ||
| The expanding universe of T-cell subsets: Th1, Th2 and more. | Q41120396 | ||
| Interleukin-4 and listeriosis | Q41603432 | ||
| Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells | Q41837371 | ||
| CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major | Q43414997 | ||
| Defective NK cell activity and Th1 response in IL-18-deficient mice | Q43595287 | ||
| IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production | Q45186185 | ||
| IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. | Q45933733 | ||
| Regulation of murine macrophage IL-12 production. Activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines | Q50140448 | ||
| IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells. | Q52539822 | ||
| Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. | Q54072853 | ||
| Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice. | Q54081891 | ||
| Rapid Death and Regeneration of NKT Cells in Anti-CD3ε- or IL-12-Treated Mice | Q59387573 | ||
| IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells | Q62589132 | ||
| Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide | Q63363342 | ||
| Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis | Q71049413 | ||
| Influence of molecular sizes of Cryptococcus neoformans capsular polysaccharide on phagocytosis | Q72649232 | ||
| A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement | Q73201950 | ||
| IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells | Q73365748 | ||
| Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice | Q73708986 | ||
| Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors | Q73889862 | ||
| In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells | Q74165026 | ||
| CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells | Q77764857 | ||
| IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family | Q77807763 | ||
| Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype | Q78145090 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cryptococcosis | Q1470140 |
| P304 | page(s) | 6643-6650 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis | |
| P478 | volume | 69 |
| Q27303293 | A glycolipid adjuvant, 7DW8-5, enhances CD8+ T cell responses induced by an adenovirus-vectored malaria vaccine in non-human primates |
| Q34714252 | Activation of natural killer T cells by alpha-galactosylceramide impairs DNA vaccine-induced protective immunity against Trypanosoma cruzi |
| Q37499317 | Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity |
| Q30387948 | Cryptococcal interactions with the host immune system. |
| Q55318324 | Functions of CD1d-Restricted Invariant Natural Killer T Cells in Antimicrobial Immunity and Potential Applications for Infection Control. |
| Q37520646 | Glucocerebroside: an evolutionary advantage for patients with Gaucher disease and a new immunomodulatory agent |
| Q41815590 | IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity |
| Q35952109 | IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms |
| Q36685545 | Immune response and immunotherapy to Cryptococcus infections |
| Q34492622 | Immunomodulation with CD40 stimulation and interleukin-2 protects mice from disseminated cryptococcosis |
| Q34688305 | Immunotherapy with ligands of natural killer T cells |
| Q37965038 | Induction of protective immunity against cryptococcosis |
| Q35213598 | Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infection |
| Q41045120 | Innate recognition of cell wall β-glucans drives invariant natural killer T cell responses against fungi |
| Q37643828 | Interleukin-17A enhances host defense against cryptococcal lung infection through effects mediated by leukocyte recruitment, activation, and gamma interferon production |
| Q53971098 | Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. |
| Q35168204 | Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo |
| Q53660956 | Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide. |
| Q35545072 | Reconstitution of innate immunity in B-chronic lymphocytic leukemia: time to reconsider the possibilities |
| Q27320844 | Relationships between Th1 or Th2 iNKT cell activity and structures of CD1d-antigen complexes: meta-analysis of CD1d-glycolipids dynamics simulations |
| Q38644509 | Role of dendritic cell-pathogen interactions in the immune response to pulmonary cryptococcal infection |
| Q35781421 | Role of granulocyte macrophage colony-stimulating factor in host defense against pulmonary Cryptococcus neoformans infection during murine allergic bronchopulmonary mycosis |
| Q43090521 | Structural elucidation of diglycosyl diacylglycerol and monoglycosyl diacylglycerol from Streptococcus pneumoniae by multiple-stage linear ion-trap mass spectrometry with electrospray ionization |
| Q34770393 | The unconventional lifestyle of NKT cells |
| Q36354705 | V alpha14 i NKT cells are innate lymphocytes that participate in the immune response to diverse microbes |
| Q37196707 | beta-Glycosphingolipids as immune modulators |
Search more.